Skip to content
Advertisement

FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company's bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week. (AP Photo/Frank Franklin II, File)

FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company's bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week. (AP Photo/Frank Franklin II, File)

Featured Photo Galleries